TXNRD2 and open-angle glaucoma: The first POAG GWAS performed in continental African participants, the Genetics in Glaucoma patients of African descent (GIGA) study, validated TXNRD2, CDKN2B-AS1, and TMCO1 loci previously reported to confer POAG risk in Europeans [31].